BACKGROUND: Nowadays in Korea, the diagnosis and treatment of the skin diseases by non-dermatologists are surprisingly frequent, and dermatologists often encounter patients who could not distinguish a non-dermatologist from a dermatologist. Thus, misdiagnoses and complications might increase as well. OBJECTIVE: This study aims to evaluate the awareness and attitudes of patients, who seek treatment for their skin diseases, toward dermatologists and non-dermatologists in Korea. METHODS: Between September and December 2014, a total 221 dermatologic outpatients, who visited Chonbuk National University Hospital, were asked to complete a questionnaire. The questions covered its accordance with their visiting intention, practical ability to differentiate a dermatologist from other specialists, criteria for choosing the clinic for skin conditions, consciousness about cutaneous treatment by dermatologists, and others. RESULTS: The ratio of male to female was 1:1.7, and the mean age was 40.5 (±13.18) years. Even though 34.8% of patients answered that they could distinguish between a dermatologist and a non-dermatologist, only 19.0% of the total patients were able to recognize the signboard of dermatologists. The most common criteria for choosing a clinic was if a dermatologist is present to administer treatment. Most patients did not want to visit a non-dermatologist for both the treatment of skin disease and cosmetic treatment. CONCLUSION: Many patients desiring dermatologic and cosmetic treatments wanted to see dermatologist; however, their ability to distinguish dermatologist from non-dermatologist was found to be very low. We suggest that the medical law in Korea needs to be improved such that the specialists are required to display a symbol issued by their own society on their signboards.
Consciousness ; Diagnosis ; Diagnostic Errors ; Female ; Humans ; Intention ; Jeollabuk-do ; Jurisprudence ; Korea* ; Male ; Outpatients* ; Skin ; Skin Diseases ; Specialization ; Tertiary Care Centers*

Sebaceous trichofolliculoma, which is a variant of trichofolliculoma, is a rare disease that clinically show a centrally depressed lesion usually singly on the nose, and histologically a centrally located cavity, lined by squamous epithelium, with numerous sebaceous lobules connected to them. We describe a case of sebaceous trichofolliculoma in a 27-year-old woman who had several brown papules on the nose. We think that this is the first report of sebaceous trichofolliculloma in Korean literature.
Adult ; Epithelium ; Female ; Humans ; Nose ; Rare Diseases

BACKGROUND AND OBJECTIVES: Uvulopalatal flap (UPF), which is a modification of UPPP, is established in the treatment of snoring and obstructive sleep apnea syndrome (OSAS) with reduced velopharyngeal incompetence (VPI) risk. This study was performed to evaluate the subjective outcome of UPF among patients with simple snoring or obstructive sleep apnea. MATERIALS AND METHODS: Twenty patients with OSAS were examined (sixteen male, four female) in a prospective manner. Subjects who underwent UPF have completed pre or post operative (after 3 months) polysomnographic (PSG) studies. The parameters of PSG were apnea index (AI), respiratory disturbance index (RDI), mean SaO2, and lowest SaO2. Questionnaires composed of Eworth sleepiness scale (ESS) and snoring symptoms inventory (SSI) were completed by patients and bed partner before and after the UPF. Statistical analysis was performed using the Wilcoxon signed rank test. RESULTS: Subjective questionnaires indicated statistically significant improvements (SSI ; from 60.9 to 37, ESS ; from 11.6 to 7.4). The AI decreased from 18.6 to 9.3, RDI decreased from 29.8 to 16.6 (p<0.05). CONCLUSION: UPF seems to be more effective in mild OSAS than in moderate and severe OSAS. Long term follow up studies with more patients is deemed necessary.
Apnea ; Follow-Up Studies ; Humans ; Male ; Polysomnography ; Prospective Studies ; Sleep Apnea, Obstructive* ; Snoring ; Velopharyngeal Insufficiency ; Surveys and Questionnaires

No abstract available.
Acute Kidney Injury* ; Hemoglobinuria, Paroxysmal*

PURPOSE: Retinopathy of prematurity(ROP) continues to be a serious problem in infants who survived with neonatal intensive care. Nevertheless, there is neither available data about the incidence of ROP which may be the basis of the epidemiology, nor analysis of the risk factors of ROP in Korea. The purpose of this retrospective study was to evaluate the incidence of ROP and to analyze perinatal risk factors of ROP. METHODS: The study population was inborn neonates of Seoul National University Hospital during the three-year period, from Jan. 1991 to Dec. 1993. The total number of infants was 5,764, and the incidence of ROP was evaluated according to gestational age and birthweight. Infants with birthweight under 1,500gram or with gestational age less than 33 weeks were involved in this study, in 168 of the 242 infants, their eyes were examined. Of these, 71 developed some degree of ROP, and 12 received cryotherapy. The comparisons of perinatal risk factors of ROP between the group with and without ROP, and in the group with ROP, between with and without cryotherapy have been made. RESULTS: 1) The cumulative incidence of ROP according to gestational age was 100% in less than 28 weeks, 96.0%, 80.4%, 66.7%, 57.3%, 44.1%, 32.2%, 23.1%, 15.8%, and 10.6% in less than 29, 30, 31, 32, 33, 34, 35, 36, and 37 weeks, respectively. 2) The cumulative incidence of ROP according to birthweight was 100% in under 750gram, 90.9%, 69.8%, 56.8%, 39.1%, 26.8%, 16.0%, and 9.9% in under 1,000gram, 1,250gram, 1,500gram, 1,750gram, 2,000gram, 2,250gram, and 2,500gram, respectively. 3) The perinatal risk factors which were statistically significant were gestational age, birthweight, Apgar score at 1 and 5 minutes, duration of hospitalization, ventilation and oxygen supply, number of transfusions, acidosis, hyperoxia, maximum fraction of inspired oxygen, maximum peak inspiratory pressure, maximum frequency, and the presence of pneumonia, apnea-bradycardia syndrome, intraventricular hemorrhage, sepsis, hypocalcemia, hyperglycemia, bronchopulmonary dysplasia, administration of aminophylline or furosemide. With linear logistic regression analysis, only gestational age (OR=0.930, 95% CI=0.887-0.975) and hyperoxia (OR=1.006, 95% CI=1.003-1.009) were proved to relate to the occurrence of ROP independently. CONCLUSIONS: ROP was developed in 44.1% of infants less than 33 weeks and in 56.8% of infants under 1,500gram and the occurrence of ROP was related significantly only to gestational age and hyperoxia.
Acidosis ; Aminophylline ; Apgar Score ; Bronchopulmonary Dysplasia ; Cryotherapy ; Epidemiology ; Furosemide ; Gestational Age ; Hemorrhage ; Hospitalization ; Humans ; Hyperglycemia ; Hyperoxia ; Hypocalcemia ; Incidence* ; Infant ; Infant, Newborn ; Intensive Care, Neonatal ; Korea ; Logistic Models ; Oxygen ; Pneumonia ; Retinopathy of Prematurity* ; Retrospective Studies ; Risk Factors* ; Seoul ; Sepsis ; Ventilation

PURPOSE: Febrile seizures affect 2-5% of all children younger than 6 years old. A small proportion of children with febrile seizures later develop epilepsy. Muations in the voltage-gated sodium channel subunit gene SCN1A have been associated with febrile seizures(FSs) in autosomal dominant generalized epilepsy with febrile seizures plus (GEFS+) families and severe myoclonic epilepsy of infancy. The present study assessed the role of SCN1A in familial typical FSs. METHODS: 22 GEFS+ and 62 FSs were selected throughout a collaborative study of Catholic Child Neurology Research Group. The exon 9 region of SCN1A was screened by DHPLC. DNA fragments showing variant chromatograms were subsequently sequenced. RESULTS: A total 84 individuals(22 GEFS+ and 62 FSs) was screened for mutations. Among 22 GEFS+ and 62 FSs patients, five and forty nine showed simple FSs, and seventeen and thirteen had complex FSs. 0% and 8.3% were younger than 12 months old, 22.7% and 46.8% were between 12 and 35 months old, 18.2% and 41.9% were between 36 and 83 months old, and 59.1% and 0% were older than 84 months old. The ratios of male to female were 1.75:1 and 1.82:1. Mutational analysis detected no mutation of SCN1A. Mutational analysis detected eleven silent exonic polymorphisms at G1212A in exon 9 and forty two polymorphisms on intron 9, and 23 intron A/As in 73 homozygote samples. There were no significant differences in allelic frequencies(G/G intron A/A or G/G, G/G intron G/A, G/A intron G/A, reported G/A) of G1212A in SCN1A-exon 9 between the patients with GEFS+ and FSs(31.8% vs. 32.3%, 54.5% vs. 54.8%, 9% vs. 6.5%, 4.5% vs. 6.5%). CONCLUSION: Although our study demonstrated that SCN1A is not frequently involved in GEFS+ and FSs, further systemic research would be necessary.
Child ; Child, Preschool ; DNA ; Epilepsies, Myoclonic ; Epilepsy ; Epilepsy, Generalized ; Exons ; Female ; Homozygote ; Humans ; Infant ; Introns ; Male ; Neurology ; Polymorphism, Single Nucleotide* ; Seizures, Febrile ; Sodium Channels

PURPOSE: Febrile seizures affect 2-5% of all children younger than 6 years old. A small proportion of children with febrile seizures later develop epilepsy. Muations in the voltage-gated sodium channel subunit gene SCN1A have been associated with febrile seizures(FSs) in autosomal dominant generalized epilepsy with febrile seizures plus (GEFS+) families and severe myoclonic epilepsy of infancy. The present study assessed the role of SCN1A in familial typical FSs. METHODS: 22 GEFS+ and 62 FSs were selected throughout a collaborative study of Catholic Child Neurology Research Group. The exon 9 region of SCN1A was screened by DHPLC. DNA fragments showing variant chromatograms were subsequently sequenced. RESULTS: A total 84 individuals(22 GEFS+ and 62 FSs) was screened for mutations. Among 22 GEFS+ and 62 FSs patients, five and forty nine showed simple FSs, and seventeen and thirteen had complex FSs. 0% and 8.3% were younger than 12 months old, 22.7% and 46.8% were between 12 and 35 months old, 18.2% and 41.9% were between 36 and 83 months old, and 59.1% and 0% were older than 84 months old. The ratios of male to female were 1.75:1 and 1.82:1. Mutational analysis detected no mutation of SCN1A. Mutational analysis detected eleven silent exonic polymorphisms at G1212A in exon 9 and forty two polymorphisms on intron 9, and 23 intron A/As in 73 homozygote samples. There were no significant differences in allelic frequencies(G/G intron A/A or G/G, G/G intron G/A, G/A intron G/A, reported G/A) of G1212A in SCN1A-exon 9 between the patients with GEFS+ and FSs(31.8% vs. 32.3%, 54.5% vs. 54.8%, 9% vs. 6.5%, 4.5% vs. 6.5%). CONCLUSION: Although our study demonstrated that SCN1A is not frequently involved in GEFS+ and FSs, further systemic research would be necessary.
Child ; Child, Preschool ; DNA ; Epilepsies, Myoclonic ; Epilepsy ; Epilepsy, Generalized ; Exons ; Female ; Homozygote ; Humans ; Infant ; Introns ; Male ; Neurology ; Polymorphism, Single Nucleotide* ; Seizures, Febrile ; Sodium Channels

Cordycepin (3'-deoxyadenosine) has been shown to exhibit many pharmacological activities, including anti-cancer, anti-inflammatory, and anti-infection activities. However, the anti-skin photoaging effects of cordycepin have not yet been reported. In the present study, we investigated the inhibitory effects of cordycepin on matrix metalloproteinase-1 (MMP-1) and -3 expressions of the human dermal fibroblast cells. Western blot analysis and real-time PCR revealed cordycepin inhibited UVB-induced MMP-1 and -3 expressions in a dose-dependent manner. UVB strongly activated NF-kappa B activity, which was determined by I kappa B alpha degradation, nuclear localization of p50 and p65 subunit, and NF-kappa B binding activity. However, UVB-induced NF-kappa B activation and MMP expression were completely blocked by cordycepin pretreatment. These findings suggest that cordycepin could prevent UVB-induced MMPs expressions through inhibition of NF-kappa B activation. In conclusion, cordycepin might be used as a potential agent for the prevention and treatment of skin photoaging.
Aging/physiology ; Cells, Cultured ; Deoxyadenosines/*pharmacology ; *Dermis/cytology/drug effects/physiology/radiation effects ; Dose-Response Relationship, Drug ; Enzyme Induction/drug effects ; Fibroblasts/drug effects/metabolism/radiation effects ; Gene Expression Regulation, Enzymologic ; Humans ; Infant, Newborn ; Male ; *Matrix Metalloproteinase 1/antagonists & inhibitors/biosynthesis/genetics/radiation effects ; Matrix Metalloproteinase 3/antagonists & inhibitors/*biosynthesis/genetics/radiation effects ; NF-kappa B/*antagonists & inhibitors/genetics/metabolism ; Skin/physiopathology/radiation effects ; *Ultraviolet Rays

Tinea incognito (TI) is a dermatophytic infection which has lost its typical clinical appearance because of improper use of steroids or calcineurin inhibitors. The incidence of TI is increasing nowadays. We conducted retrospective review on 283 patients with TI from 25 dermatology training hospitals in Korea from 2002-2010 to investigate the demographical, clinical, and mycological characteristics of TI, and to determine the associated risk factors. More than half (59.3%) patients were previously treated by non-dermatologists or self-treated. The mean duration of TI was 15.0 +/- 25.3 months. The most common clinical manifestations were eczema-like lesion, psoriasis-like, and lupus erythematosus-like lesion. The trunk and face were frequently involved, and 91 patients (32.2%) also had coexisting fungal infections. Among 67 isolated strains, Trichophyton rubrum was the most frequently detected (73.1%). This is the largest study of TI reported to date and the first investigational report concerning TI in Korea. We suggest that doctors should consider TI when a patient has intractable eczema-like lesions accompanied by tinea pedis/unguium. Furthermore, there should be a policy change, which would make over-the-counter high-potency topical steroids less accessible in some countries, including Korea.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Demography ; Eczema/pathology ; Face/pathology ; Female ; Humans ; Lupus Erythematosus, Cutaneous/pathology ; Male ; Middle Aged ; Psoriasis/pathology ; Republic of Korea ; Retrospective Studies ; Risk Factors ; Tinea/*diagnosis/microbiology ; Trichophyton/isolation & purification ; Young Adult